二十年肾脏病研究：进展与未来挑战。

IF 39.8 1区医学 Q1 UROLOGY & NEPHROLOGY

Nature Reviews Nephrology Pub Date : 2025-09-19 DOI:10.1038/s41581-025-00996-5

Urmila Anandh, Hans-Joachim Anders, Justine Bacchetta, David W Johnson, Valerie Luyckx, Giuseppe Remuzzi, Bernardo Rodriguez-Iturbe, Katalin Susztak, Katherine Tuttle, Motoko Yanagita

{"title":"二十年肾脏病研究：进展与未来挑战。","authors":"Urmila Anandh, Hans-Joachim Anders, Justine Bacchetta, David W Johnson, Valerie Luyckx, Giuseppe Remuzzi, Bernardo Rodriguez-Iturbe, Katalin Susztak, Katherine Tuttle, Motoko Yanagita","doi":"10.1038/s41581-025-00996-5","DOIUrl":null,"url":null,"abstract":"Since publication of the first issue of Nature Reviews Nephrology 20 years ago, advances across various subspecialities of nephrology have provided insights into disease processes and led to the development of new therapeutics for people with kidney disease. However, despite this progress, many kidney diseases remain untreatable, the costs of kidney disease care are immense, and vast inequities persist in disease burden and access to care. In this Viewpoint, we ask experts from several key subspecialties of nephrology to reflect on progress made over the past 20 years, remaining challenges and the steps needed to move the field forward.","PeriodicalId":19059,"journal":{"name":"Nature Reviews Nephrology","volume":"21 11","pages":"727-735"},"PeriodicalIF":39.8000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Two decades of nephrology research: progress and future challenges\",\"authors\":\"Urmila Anandh, Hans-Joachim Anders, Justine Bacchetta, David W Johnson, Valerie Luyckx, Giuseppe Remuzzi, Bernardo Rodriguez-Iturbe, Katalin Susztak, Katherine Tuttle, Motoko Yanagita\",\"doi\":\"10.1038/s41581-025-00996-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since publication of the first issue of Nature Reviews Nephrology 20 years ago, advances across various subspecialities of nephrology have provided insights into disease processes and led to the development of new therapeutics for people with kidney disease. However, despite this progress, many kidney diseases remain untreatable, the costs of kidney disease care are immense, and vast inequities persist in disease burden and access to care. In this Viewpoint, we ask experts from several key subspecialties of nephrology to reflect on progress made over the past 20 years, remaining challenges and the steps needed to move the field forward.\",\"PeriodicalId\":19059,\"journal\":{\"name\":\"Nature Reviews Nephrology\",\"volume\":\"21 11\",\"pages\":\"727-735\"},\"PeriodicalIF\":39.8000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Reviews Nephrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41581-025-00996-5\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews Nephrology","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41581-025-00996-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

自20年前《自然肾脏病评论》第一期出版以来，肾脏病学各个亚专科的进展提供了对疾病过程的见解，并导致了肾病患者新治疗方法的发展。然而，尽管取得了这些进展，许多肾脏疾病仍然无法治愈，肾脏疾病护理的费用巨大，在疾病负担和获得护理方面仍然存在巨大的不公平现象。在这篇文章中，我们邀请了来自肾脏学几个关键亚专业的专家来反思过去20年的进展、仍然存在的挑战以及推动该领域向前发展所需的步骤。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Two decades of nephrology research: progress and future challenges

Since publication of the first issue of Nature Reviews Nephrology 20 years ago, advances across various subspecialities of nephrology have provided insights into disease processes and led to the development of new therapeutics for people with kidney disease. However, despite this progress, many kidney diseases remain untreatable, the costs of kidney disease care are immense, and vast inequities persist in disease burden and access to care. In this Viewpoint, we ask experts from several key subspecialties of nephrology to reflect on progress made over the past 20 years, remaining challenges and the steps needed to move the field forward.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Reviews Nephrology 医学-泌尿学与肾脏学

CiteScore

39.00

自引率

1.20%

发文量

127

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Nephrology aims to be the premier source of reviews and commentaries for the scientific communities it serves. It strives to publish authoritative, accessible articles. Articles are enhanced with clearly understandable figures, tables, and other display items. Nature Reviews Nephrology publishes Research Highlights, News & Views, Comments, Reviews, Perspectives, and Consensus Statements. The content is relevant to nephrologists and basic science researchers. The broad scope of the journal ensures that the work reaches the widest possible audience.